Zivo Bioscience, Inc. · OTC:ZIVO
Zivo Bioscience — Investor Presentation (January 2023)
10 slides from Zivo Bioscience's investor presentation, January 2023
Slide 1: Transformative Opportunities in Therapeutics & Nutrition
(Nasdaq: ZIVO) Transformative Opportunities in Therapeutics & Nutrition January 2023
Slide 2: Disclaimer
Disclaimer SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Some of the statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These sta
Slide 3: Investment Overview
Investment Overview One Natural Source. Numerous Value-Driving Opportunities. Developing novel therapeutic candidates and nutritional functional food ingredients to power immune health Near-Term Revenue: • Via out-licensing IP for a product candidate for the treatment of coccidiosis in poultry • Com
Slide 4: Zivo Bioscience, Inc. – At a Glance
Zivo Bioscience, Inc. – At a Glance One Natural Source. Numerous Value-Driving Opportunities. Therapeutics (biotech) Nutrition (agtech) • Isolation, identification and development of extracts, • Growth and distribution of Zivo’s proprietary whole fractions, or molecules derived from proprietary alga
Slide 5: Significant Market Opportunity in Therapeutic Markets
Significant Market Opportunity in Therapeutic Markets Novel active compounds have broad applicability for treatment of disease Poultry Study Results Market Opportunity Performed twenty poultry studies to evaluate the efficacy in the treatment of coccidiosis $10 billion Validated efficacy and mechani
Slide 6: Therapeutic Long Term Opportunities
Therapeutic Long Term Opportunities ZIVO intends to evaluate additional therapeutic opportunities and will employ a business model to license its proprietary molecules or bioproducts to monetize its intellectual property portfolio across multiple applications Poultry Other (Livestock) Porcine (Lives
Slide 7: Significant Market Opportunity in Nutritional Markets
Significant Market Opportunity in Nutritional Markets Proprietary dried algal biomass as a food or food ingredient Nutritive compounds found in ZIVO algae support functional food ingredients designed to enhance health in humans and animals Market Opportunity Cultivation model: $6.3 billion in 2021
Slide 8: Where ZIVO is Headed – Goals for 2023 and Beyond
Where ZIVO is Headed – Goals for 2023 and Beyond Therapeutics Nutrition Algal Biomass Biotechnology Molecules Agricultural Technology Enhanced Products Compounds Complexes Poultry Digestive Health Strategic Partnerships & Regional Distributors Prospective licensing or joint development deal Esta
Slide 9: Leadership Team
Leadership Team John B. Payne – President and CEO Harlan L. Miller III, PhD – VP Technology and Global Supply Served on ZIVO’s Board since 2013 and Chairman since 2019. He Dr. Miller is a recognized expert in algal production systems, has a significant management experience in publicly-traded previo
Slide 10: Investment Recap
Investment Recap One Natural Source. Numerous Value-Driving Opportunities. Developing novel therapeutic candidates and nutritional functional food ingredients to power immune health Near-Term Revenue: • Via out-licensing IP for a product candidate for the treatment of coccidiosis in poultry • Commer
ZIVO Bioscience — Investor Presentation (January 2023) on 6ix